Impaired insulin signalling and allostatic load in Alzheimer disease
The discovery of insulin in 1921 revolutionized the treatment of diabetes and paved the way
for numerous studies on hormone signalling networks and actions in peripheral tissues and …
for numerous studies on hormone signalling networks and actions in peripheral tissues and …
[HTML][HTML] Interaction between Aβ and tau in the pathogenesis of Alzheimer's disease
H Zhang, W Wei, M Zhao, L Ma, X Jiang… - … journal of biological …, 2021 - ncbi.nlm.nih.gov
Extracellular neuritic plaques composed of amyloid‑β (Aβ) protein and intracellular
neurofibrillary tangles containing phosphorylated tau protein are the two hallmark proteins of …
neurofibrillary tangles containing phosphorylated tau protein are the two hallmark proteins of …
The role of PI3K/Akt and ERK in neurodegenerative disorders
SN Rai, H Dilnashin, H Birla, SS Singh, W Zahra… - Neurotoxicity …, 2019 - Springer
Abstract Disruption of Akt and Erk-mediated signal transduction significantly contributes in
the pathogenesis of various neurodegenerative diseases (NDs), such as Parkinson's …
the pathogenesis of various neurodegenerative diseases (NDs), such as Parkinson's …
Epigallocatechin-3-Gallate (EGCG): New therapeutic perspectives for neuroprotection, aging, and neuroinflammation for the modern age
A Payne, S Nahashon, E Taka, GM Adinew… - Biomolecules, 2022 - mdpi.com
Alzheimer's and Parkinson's diseases are the two most common forms of neurodegenerative
diseases. The exact etiology of these disorders is not well known; however, environmental …
diseases. The exact etiology of these disorders is not well known; however, environmental …
[HTML][HTML] Pathological roles of MAPK signaling pathways in human diseases
EK Kim, EJ Choi - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2010 - Elsevier
The mammalian family of mitogen-activated protein kinases (MAPKs) includes extracellular
signal-regulated kinase (ERK), p38, and c-Jun NH2-terminal kinase (JNK), with each MAPK …
signal-regulated kinase (ERK), p38, and c-Jun NH2-terminal kinase (JNK), with each MAPK …
Molecular mechanisms of neurodegeneration in Alzheimer's disease
L Crews, E Masliah - Human molecular genetics, 2010 - academic.oup.com
Alzheimer's disease (AD) is characterized by cognitive impairment, progressive
neurodegeneration and formation of amyloid-β (Aβ)-containing plaques and neurofibrillary …
neurodegeneration and formation of amyloid-β (Aβ)-containing plaques and neurofibrillary …
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease–is this type 3 diabetes?
E Steen, BM Terry, E J. Rivera… - Journal of …, 2005 - journals.sagepub.com
The neurodegeneration that occurs in sporadic Alzheimer's disease (AD) is consistently
associated with a number of characteristic histopathological, molecular, and biochemical …
associated with a number of characteristic histopathological, molecular, and biochemical …
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
Background Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of
Alzheimer's disease (AD) and is considered to result from neurodegeneration. T-tau levels …
Alzheimer's disease (AD) and is considered to result from neurodegeneration. T-tau levels …
Prediction of Alzheimer's disease using blood gene expression data
Identification of AD (Alzheimer's disease)-related genes obtained from blood samples is
crucial for early AD diagnosis. We used three public datasets, ADNI, AddNeuroMed1 …
crucial for early AD diagnosis. We used three public datasets, ADNI, AddNeuroMed1 …
The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target
J Sun, G Nan - International journal of molecular …, 2017 - spandidos-publications.com
Signaling pathways are critical modulators of a variety of physiological and pathological
processes, and the abnormal activation of some signaling pathways can contribute to …
processes, and the abnormal activation of some signaling pathways can contribute to …